FARALLON CAPITAL MANAGEMENT LLC Q2 2021 Filing
Filed August 13, 2021
Portfolio Value
$22.5B
Holdings
287
Report Date
Q2 2021
Filing Type
13F-HR
All Holdings (287 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | RCKTROCKET PHARMACEUTICALS INC | 350,000 | $15.5B | 68.94% | |
| 102 | —ZEALAND PHARMA A/S | 510,000 | $15.1B | 67.02% | |
| 103 | —BIG SKY GROWTH PARTNERS INC | 1,550,000 | $15.0B | 66.62% | |
| 104 | —KKR ACQUISITION HOLDING I CO | 1,500,000 | $14.7B | 65.51% | |
| 105 | —AUSTERLITZ ACQUISITION CORP | 1,500,000 | $14.6B | 64.91% | |
| 106 | PLRXPLIANT THERAPEUTICS INC | 490,000 | $14.3B | 63.46% | |
| 107 | ORTXUSDORCHARD THERAPEUTICS PLC | 3,215,434 | $14.1B | 62.78% | |
| 108 | —DISRUPTIVE ACQUISITION CORP | 1,400,000 | $13.6B | 60.39% | |
| 109 | BEKEKE HLDGS INC | 273,000 | $13.0B | 57.89% | |
| 110 | —FOREST ROAD ACQUISITION COR | 1,250,000 | $12.3B | 54.48% | |
| 111 | —AGILE GROWTH CORP | 1,200,000 | $11.6B | 51.60% | |
| 112 | DRIOEURDARIOHEALTH CORP | 540,000 | $11.5B | 51.29% | |
| 113 | —GORES METROPOULOS II INC | 1,100,000 | $10.9B | 48.38% | |
| 114 | —TIGA ACQUISITION CORP | 1,080,000 | $10.8B | 48.17% | |
| 115 | KPTI 3 10/15/25KARYOPHARM THERAPEUTICS INC | 10,000,000 | $10.5B | 46.50% | |
| 116 | —FS DEVELOPMENT CORP II | 1,000,000 | $10.0B | 44.47% | |
| 117 | —FIFTH WALL ACQUISITN CORP III | 1,000,000 | $9.9B | 44.25% | |
| 118 | —VIRGIN GROUP ACQUISIT CORP I | 1,000,000 | $9.8B | 43.54% | |
| 119 | —CASCADE ACQUISITION CORP | 990,000 | $9.8B | 43.50% | |
| 120 | —FORUM MERGER IV CORP | 1,000,000 | $9.8B | 43.47% | |
| 121 | 698ACHILLES THERAPEUTICS PLC | 996,540 | $9.8B | 43.39% | |
| 122 | —ARES ACQUISITION CORPORATION | 1,000,000 | $9.8B | 43.36% | |
| 123 | CCIXCHURCHILL CAPITAL CORP VII | 1,000,000 | $9.7B | 43.27% | |
| 124 | —CORAZON CAPITAL V838 MONOCER | 1,000,000 | $9.7B | 43.14% | |
| 125 | —TAILWIND TWO ACQUISITION COR | 1,000,000 | $9.7B | 42.96% | |
| 126 | HIGHARTFORD FINL SVCS GROUP INC | 150,000 | $9.3B | 41.34% | |
| 127 | YB4PSAVARA INC | 5,452,086 | $9.3B | 41.22% | |
| 128 | QUREUNIQURE NV | 300,000 | $9.2B | 41.09% | |
| 129 | BDQMALBIREO PHARMA INC | 250,000 | $8.8B | 39.11% | |
| 130 | PACBPACIFIC BIOSCIENCES CALIF IN | 250,000 | $8.7B | 38.88% | |
| 131 | —ARYA SCIENCES ACQU CORP IV | 800,000 | $8.6B | 38.14% | |
| 132 | NVV1NOVAVAX INC | 40,000 | $8.5B | 37.77% | |
| 133 | —POST HOLDINGS PARTNERING COR | 800,000 | $8.3B | 36.96% | |
| 134 | —MEDALLIA INC | 240,000 | $8.1B | 36.02% | |
| 135 | APLS 3.5 09/15/26APELLIS PHARMACEUTICALS INC | 4,250,000 | $8.0B | 35.56% | |
| 136 | —LEVERE HOLDINGS CORP | 800,000 | $7.8B | 34.79% | |
| 137 | JWSMFJAWS MUSTANG ACQUISITION COR | 800,000 | $7.8B | 34.72% | |
| 138 | —CATALYST PARTNRS ACQUISITN C | 753,900 | $7.6B | 33.66% | |
| 139 | —TPG PACE BENEFICIAL II CORP | 750,000 | $7.6B | 33.62% | |
| 140 | —PANACEA ACQUISITION CORP II | 750,000 | $7.5B | 33.35% | |
| 141 | —RESEARCH ALLIANCE CORP II | 750,000 | $7.5B | 33.35% | |
| 142 | SURFUSDSURFACE ONCOLOGY INC | 1,000,000 | $7.5B | 33.18% | |
| 143 | —VECTOR ACQUISITION CORP II | 750,000 | $7.4B | 33.12% | |
| 144 | —GORES HOLDINGS VII INC | 750,000 | $7.4B | 33.02% | |
| 145 | —REINVENT TECHNOLOGY PARTNERS | 750,000 | $7.4B | 32.95% | |
| 146 | —WARBURG PINCUS CAPTAL CORP I | 750,000 | $7.4B | 32.95% | |
| 147 | —WARBURG PINCUS CAPTAL CORP I | 750,000 | $7.4B | 32.92% | |
| 148 | —LONGBOARD PHARMACEUTICALS IN | 810,500 | $7.4B | 32.87% | |
| 149 | —ARCLIGHT CLEAN TRANSITION II | 750,000 | $7.4B | 32.79% | |
| 150 | —PATHFINDER ACQUISITION CORP | 750,000 | $7.4B | 32.70% | |
| 151 | —APOLLO STRATEGIC GRWT CPTL I | 750,000 | $7.3B | 32.49% | |
| 152 | —THUNDER BRIDGE CAP PRTNRS II | 750,000 | $7.3B | 32.42% | |
| 153 | —SOCIAL LEVERAGE ACQUISN CORP | 750,000 | $7.3B | 32.42% | |
| 154 | —KHOSLA VENTURES ACQUISITION | 700,000 | $6.9B | 30.79% | |
| 155 | —NOVUS CAPITAL CORPORATION II | 700,000 | $6.8B | 30.35% | |
| 156 | —SUPERNOVA PARTN ACQ CO III L | 700,000 | $6.8B | 30.29% | |
| 157 | —AVROBIO INC | 740,000 | $6.6B | 29.26% | |
| 158 | —RADIUS HEALTH INC | 6,783,000 | $6.3B | 27.87% | |
| 159 | —GORES TECHNOLOGY PARTNERS II | 600,000 | $5.9B | 26.44% | |
| 160 | —VPC IMPACT ACQU HOLDI III IN | 600,000 | $5.9B | 26.39% | |
| 161 | —INTERPRIVATE IV INFRATECH PR | 600,000 | $5.8B | 26.02% | |
| 162 | —RXR ACQUISITION CORP | 600,000 | $5.8B | 25.91% | |
| 163 | —FINSERV ACQUISITION CORP II | 600,000 | $5.8B | 25.88% | |
| 164 | KRYSKRYSTAL BIOTECH INC | 75,000 | $5.1B | 22.68% | |
| 165 | —SOARING EAGLE ACQUISITION CO | 500,000 | $5.0B | 22.15% | |
| 166 | —HUMANCO ACQUISITION CORP | 508,900 | $5.0B | 22.07% | |
| 167 | —TCV ACQUISITION CORP | 500,000 | $5.0B | 22.04% | |
| 168 | IMGNEURIMMUNOGEN INC | 750,000 | $4.9B | 21.98% | |
| 169 | —G SQUARED ASCEND I INC | 500,000 | $4.9B | 21.95% | |
| 170 | —FIFTH WALL ACQUISITION CORP | 400,000 | $4.9B | 21.90% | |
| 171 | —ROCKET INTERNET GRWT OPRT CO | 500,000 | $4.9B | 21.86% | |
| 172 | —LANDCADIA HOLDINGS IV INC | 500,000 | $4.9B | 21.72% | |
| 173 | —COLONNADE ACQUISITION CORP I | 500,000 | $4.9B | 21.72% | |
| 174 | —FTAC HERA ACQUISITION CORP | 500,000 | $4.9B | 21.68% | |
| 175 | COGTCOGENT BIOSCIENCES INC | 600,000 | $4.9B | 21.64% | |
| 176 | —TIO TECH A | 500,000 | $4.8B | 21.52% | |
| 177 | —SCION TECH GROWTH II | 450,000 | $4.4B | 19.41% | |
| 178 | KURAKURA ONCOLOGY INC | 200,000 | $4.2B | 18.54% | |
| 179 | —VPC IMPACT ACQUISITION HLDG | 425,000 | $4.2B | 18.49% | |
| 180 | —GORES HLDGS VIII INC | 400,000 | $4.0B | 17.65% | |
| 181 | CCIXCHURCHILL CAPITAL CORP VI | 400,000 | $3.9B | 17.54% | |
| 182 | —NIGHTDRAGON ACQUISITION CORP | 400,000 | $3.9B | 17.36% | |
| 183 | —INTERPRIVATE II ACQUISITION | 400,000 | $3.9B | 17.26% | |
| 184 | —INTERPRIVATE III FINANCIAL P | 400,000 | $3.9B | 17.26% | |
| 185 | —FIRST RESERVE SUSTAINABLE GW | 400,000 | $3.9B | 17.24% | |
| 186 | —TPG PACE SOLUTIONS CORP | 350,000 | $3.5B | 15.50% | |
| 187 | —BCTG ACQUISITION CORP | 300,000 | $3.4B | 15.17% | |
| 188 | GRFSGRIFOLS S A | 172,738 | $3.0B | 13.33% | |
| 189 | —LONGVIEW ACQUISITION CORP II | 304,698 | $3.0B | 13.28% | |
| 190 | —LAZARD GROWTH ACQUISITION CO | 300,000 | $2.9B | 13.05% | |
| 191 | —NORTHERN GENESIS ACQUISITION | 278,026 | $2.8B | 12.30% | |
| 192 | —FINCH THERAPEUTICS GROUP INC | 185,344 | $2.6B | 11.60% | |
| 193 | —GORES TECHNOLOGY PARTNERS IN | 250,000 | $2.5B | 11.18% | |
| 194 | —DRAGONEER GROWTH OPT CORP II | 250,000 | $2.5B | 11.12% | |
| 195 | —SVF INVESTMENT CORP | 250,000 | $2.5B | 10.98% | |
| 196 | LOBLIVE OAK MOBILITY ACQUISI CO | 250,000 | $2.5B | 10.90% | |
| 197 | —HUDSON EXECUTIVE INVES III | 250,000 | $2.4B | 10.85% | |
| 198 | CVA1EURCOVANTA HLDG CORP | 115,000 | $2.0B | 9.01% | |
| 199 | —ARCTOS NORTHSTAR ACQUIS CORP | 200,000 | $1.9B | 8.65% | |
| 200 | —SUPERNOVA PARTNERS ACQUISTN | 200,000 | $1.9B | 8.64% |